U.S. Colorectal Cancer Screening Market: Government Initiatives and Policy Support
The U.S. government has been at the forefront of efforts to combat colorectal cancer (CRC) through a range of initiatives aimed at improving screening rates, increasing public awareness, and ensuring equitable access to early detection services. With colorectal cancer being the second leading cause of cancer-related deaths in the country, federal and state-level policies play a crucial role in shaping the colorectal cancer screening market. This article explores the government’s involvement in the fight against CRC and the policies that support colorectal cancer screening in the U.S.
U.S. colorectal cancer screening market size was valued at US$ 5.95 Bn in 2023 and is expected to reach US$ 10.62 Bn by 2031, grow at a compound annual growth rate (CAGR) of 7.5% from 2024 to 2031.
One of the most significant contributions of the U.S. Colorectal Cancer Screening Market is the development of evidence-based guidelines. The U.S. Preventive Services Task Force (USPSTF) provides recommendations on when and how individuals should be screened for colorectal cancer. In 2021, the USPSTF updated its guidelines to recommend screening for individuals aged 45 to 75, reflecting the rising incidence of colorectal cancer among younger adults. This change marked a significant shift in screening protocols and has contributed to the growing demand for screening services.
Get More Insights On- U.S. Colorectal Cancer Screening Market
Get This Report in Japanese Language: 米国大腸がん検査市場
Get This Report in Korean Language: 미국 대장암 검진 시장
Explore More Related Articles: Green Polymers: The Future of Sustainable Materials
English
Arabic
Français
Español
Português
Deutsch
Türkçe
Dutch
Russian
Romaian